{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:53:49Z","timestamp":1788850429761,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:00:00Z","timestamp":1711065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100022706","name":"Cole Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020867","name":"The Montreal Children\u2019s Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020867","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de recherche du Qu\u00e9bec Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023447","name":"CHU Sainte-Justine Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009447","name":"Leukemia and Lymphoma Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009447","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.leukres.2024.107485","type":"journal-article","created":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T05:09:46Z","timestamp":1710565786000},"page":"107485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Mathematical modelling of clonal reduction therapeutic strategies in acute myeloid leukemia"],"prefix":"10.1016","volume":"140","author":[{"given":"Mia","family":"Brunetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella A.","family":"Iasenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrianne L.","family":"Jenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00ebl J.-M.","family":"Raynal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kolja","family":"Eppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.leukres.2024.107485_bib1","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of aml in adults: 2017 eln recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.leukres.2024.107485_bib2","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1080\/14656566.2017.1391216","article-title":"Cytarabine and daunorubicin for the treatment of acute myeloid leukemia","volume":"18","author":"Murphy","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"issue":"2","key":"10.1016\/j.leukres.2024.107485_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","article-title":"Acute myeloid leukemia: current progress and future directions","volume":"11","author":"Kantarjian","year":"2021","journal-title":"Blood Cancer J."},{"issue":"6464","key":"10.1016\/j.leukres.2024.107485_bib4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into scid mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.leukres.2024.107485_bib5","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/nbt1350","article-title":"Chemotherapy-resistant human aml stem cells home to and engraft within the bone-marrow endosteal region","volume":"25","author":"Ishikawa","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"7","key":"10.1016\/j.leukres.2024.107485_bib6","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.leukres.2024.107485_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41568-020-0245-2","article-title":"Bone marrow niches in haematological malignancies","volume":"20","author":"M\u00e9ndez-Ferrer","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.leukres.2024.107485_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12020441","article-title":"Repurposing drugs for acute myeloid leukemia: a worthy cause or a futile pursuit","volume":"12","author":"Wojcicki","year":"2020","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.leukres.2024.107485_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41408-018-0087-2","article-title":"Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia","volume":"8","author":"Laverdi\u00e8re","year":"2018","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.leukres.2024.107485_bib10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s13046-019-1242-8","article-title":"Heart failure drug proscillaridin a targets myc overexpressing leukemia through global loss of lysine acetylation","volume":"38","author":"Da Costa","year":"2019","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"4","key":"10.1016\/j.leukres.2024.107485_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003599","article-title":"Feedback signals in myelodysplastic syndromes: increased self-renewal of the malignant clone suppresses normal hematopoiesis","volume":"10","author":"Walenda","year":"2014","journal-title":"PLoS Comput. Biol."},{"issue":"8","key":"10.1016\/j.leukres.2024.107485_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183620","article-title":"Mathematical modelling as a proof of concept for mpns as a human inflammation model for cancer development","volume":"12","author":"Andersen","year":"2017","journal-title":"PLOS ONE"},{"issue":"6","key":"10.1016\/j.leukres.2024.107485_bib13","doi-asserted-by":"crossref","first-page":"8268","DOI":"10.3934\/mbe.2019418","article-title":"Mathematical analysis of the cancitis model and the role of inflammation in blood cancer progression","volume":"16","author":"Zamra","year":"2019","journal-title":"Math. Biosci. Eng."},{"key":"10.1016\/j.leukres.2024.107485_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.mbs.2021.108541","article-title":"Stochastic stem cell models with mutation: a comparison of asymmetric and symmetric divisions","volume":"332","author":"Wu","year":"2021","journal-title":"Math. Biosci."},{"issue":"3","key":"10.1016\/j.leukres.2024.107485_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.0030053","article-title":"a)symmetric stem cell replication and cancer","volume":"3","author":"Dingli","year":"2007","journal-title":"PLOS Comput. Biol."},{"issue":"10","key":"10.1016\/j.leukres.2024.107485_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204393","article-title":"A stochastic model of myeloid cell lineages in hematopoiesis and pathway mutations in acute myeloid leukemia","volume":"13","author":"J\u00e4kel","year":"2018","journal-title":"PLOS ONE"},{"issue":"5","key":"10.1016\/j.leukres.2024.107485_bib17","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.cell.2021.01.049","article-title":"Increased stem cell proliferation in atherosclerosis accelerates clonal hematopoiesis","volume":"184","author":"Heyde","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2024.107485_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.00806","article-title":"Application of the moran model in estimating selection coefficient of mutated csf3r clones in the evolution of severe congenital neutropenia to myeloid neoplasia","volume":"11","author":"Dinh","year":"2020","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.leukres.2024.107485_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006664","article-title":"Mutation, drift and selection in single-driver hematologic malignancy: example of secondary myelodysplastic syndrome following treatment of inherited neutropenia","volume":"15","author":"Wojdyla","year":"2019","journal-title":"PLOS Comput. Biol."},{"issue":"1","key":"10.1016\/j.leukres.2024.107485_bib20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1017\/S0305004100033193","article-title":"Random processes in genetics","volume":"54","author":"Moran","year":"1958","journal-title":"Math. Proc. Camb. Philos. Soc."},{"issue":"11","key":"10.1016\/j.leukres.2024.107485_bib21","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1021\/np050226l","article-title":"Digitoxin inhibits the growth of cancer cell lines at concentrations commonly found in cardiac patients","volume":"68","author":"L\u00f3pez-L\u00e1zaro","year":"2005","journal-title":"J. Nat. Prod."},{"issue":"15","key":"10.1016\/j.leukres.2024.107485_bib22","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1038\/sj.onc.1202555","article-title":"Tiam1 is involved in the regulation of bufalin-induced apoptosis in human leukemia cells","volume":"18","author":"Kawazoe","year":"1999","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.leukres.2024.107485_bib23","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00001813-200106000-00009","article-title":"Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells","volume":"12","author":"Johansson","year":"2001","journal-title":"AntiCancer Drugs"},{"issue":"22","key":"10.1016\/j.leukres.2024.107485_bib24","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1158\/1078-0432.CCR-17-1259","article-title":"Chemogenomic landscape of runx1-mutated aml reveals importance of runx1 allele dosage in genetics and glucocorticoid sensitivity","volume":"23","author":"Simon","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.leukres.2024.107485_bib25","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/leu.2016.314","article-title":"Enhanced sensitivity to glucocorticoids in cytarabine-resistant aml","volume":"31","author":"Malani","year":"2017","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.leukres.2024.107485_bib26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0145-2126(96)00089-6","article-title":"Glucocorticoids induce apoptosis in acute myeloid leukemia cell lines with a t(8;21) chromosome translocation","volume":"21","author":"Miyoshi","year":"1997","journal-title":"Leuk. Res"},{"issue":"6485","key":"10.1016\/j.leukres.2024.107485_bib27","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1126\/science.aay9333","article-title":"The evolutionary dynamics and fitness landscape of clonal hematopoiesis","volume":"367","author":"Watson","year":"2020","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.leukres.2024.107485_bib28","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1177\/009127000004001107","article-title":"Bioavailability and metabolism of mometasone furoate following administration by metered-dose and dry-powder inhalers in healthy human volunteers","volume":"40","author":"Affrime","year":"2000","journal-title":"J. Clin. Pharm."},{"issue":"2","key":"10.1016\/j.leukres.2024.107485_bib29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00609467","article-title":"Pharmacokinetics and pharmacodynamics of methyl proscillaridin in healthy man","volume":"10","author":"Belz","year":"1976","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.leukres.2024.107485_bib30","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1081-1206(10)62146-1","article-title":"Systemic availability and lung deposition of budesonide via three different nebulizers in adults","volume":"90","author":"Dahlstr\u00f6m","year":"2003","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"16","key":"10.1016\/j.leukres.2024.107485_bib31","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/BF01721922","article-title":"Pharmacokinetics and pharmacodynamics of intravenous digoxin and digitoxin","volume":"59","author":"Ochs","year":"1981","journal-title":"Klin. Woche"},{"issue":"6","key":"10.1016\/j.leukres.2024.107485_bib32","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/01.CIR.45.6.1176","article-title":"Ouabain pharmacokinetics in dog and man. Determination by radioimmunoassay","volume":"45","author":"Selden","year":"1972","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.leukres.2024.107485_bib33","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00280-011-1800-z","article-title":"Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemia","volume":"69","author":"Krogh-Madsen","year":"2012","journal-title":"Cancer Chemother. Pharm."},{"issue":"7724","key":"10.1016\/j.leukres.2024.107485_bib34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41586-018-0497-0","article-title":"Population dynamics of normal human blood inferred from somatic mutations","volume":"561","author":"Lee-Six","year":"2018","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.leukres.2024.107485_bib35","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1073\/pnas.1011414108","article-title":"Predicting clonal self-renewal and extinction of hematopoietic stem cells","volume":"108","author":"Sieburg","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.leukres.2024.107485_bib36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/bs.ctdb.2016.01.009","article-title":"Hematopoietic stem cell and its bone marrow niche","volume":"118","author":"Yu","year":"2016","journal-title":"Curr. Top. Dev. Biol."},{"issue":"8","key":"10.1016\/j.leukres.2024.107485_bib37","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1182\/blood.V92.8.2629","article-title":"Cyclical neutropenia and other periodic hematological disorders: a review of mechanisms and mathematical models","volume":"92","author":"Haurie","year":"1998","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2024.107485_bib38","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1365-2184.2009.00598.x","article-title":"Progenitor cell self-renewal and cyclic neutropenia","volume":"42","author":"Dingli","year":"2009","journal-title":"Cell Prolif."},{"issue":"7","key":"10.1016\/j.leukres.2024.107485_bib39","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1182\/blood-2002-03-0822","article-title":"Evidence that the number of hematopoietic stem cells per animal is conserved in mammals","volume":"100","author":"Abkowitz","year":"2002","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2024.107485_bib40","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/1947601910377495","article-title":"Myc roles in hematopoiesis and leukemia","volume":"1","author":"Delgado","year":"2010","journal-title":"Genes Cancer"},{"issue":"2","key":"10.1016\/j.leukres.2024.107485_bib41","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ccell.2015.12.011","article-title":"Mir-126 regulates distinct self-renewal outcomes in normal and malignant hematopoietic stem cells","volume":"29","author":"Lechman","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2024.107485_bib42","unstructured":"MATLAB. Version 9.8.0 (r2020a). Natick, Massachusetts: The MathWorks Inc.; 2020."},{"key":"10.1016\/j.leukres.2024.107485_bib43","unstructured":"Monolix 2021R2, Lixoft SAS, a Simulations Plus company."},{"issue":"1","key":"10.1016\/j.leukres.2024.107485_bib44","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1038\/s41598-017-02496-4","article-title":"Identification of na+\/k+-atpase inhibition-independent proarrhythmic ionic mechanisms of cardiac glycosides","volume":"7","author":"Koh","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.leukres.2024.107485_bib45","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/bcp.12814","article-title":"Pharmacological treatment of cardiac glycoside poisoning","volume":"81","author":"Roberts","year":"2016","journal-title":"Br. J. Clin. Pharm."},{"issue":"16","key":"10.1016\/j.leukres.2024.107485_bib46","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0024-3205(00)00779-7","article-title":"Selective inhibition of human erythrocyte na+\/k+ atpase by cardiac glycosides and by a mammalian digitalis like factor","volume":"67","author":"Balzan","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.leukres.2024.107485_bib47","unstructured":"Rehman R., Dawson A.H., Hai O. Digitalis toxicity. Statpearls [internet]: StatPearls Publishing; 2022."},{"key":"10.1016\/j.leukres.2024.107485_bib48","unstructured":"M. Yasir, A. Goyal, S. SonthaliaCorticosteroid Adverse Effects. 2023 Jul 3 Treasure Island (FL) , StatPearls Publishing , StatPearls [Internet] , 2023Jan\u2013. PMID: 30285357Corticosteroid Adverse Effects. Jul 3, 2023."},{"issue":"2","key":"10.1016\/j.leukres.2024.107485_bib49","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001387","article-title":"In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity","volume":"9","author":"Jenner","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"11","key":"10.1016\/j.leukres.2024.107485_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007495","article-title":"Determinants of combination gm-csf immunotherapy and oncolytic virotherapy success identified through in silico treatment personalization","volume":"15","author":"Cassidy","year":"2019","journal-title":"PLoS Comput. Biol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212624000511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212624000511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T13:02:34Z","timestamp":1714654954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212624000511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":50,"alternative-id":["S0145212624000511"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2024.107485","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mathematical modelling of clonal reduction therapeutic strategies in acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2024.107485","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107485"}}